The “Aa3” rating affirmation is based on a number of factors, including SHC’s strong financial performance, above average revenue growth and solid market position as one of two key academic medical centers in the Bay Area.
The “P-1” and “VMIG 1” ratings are based on the strength of SHC’s self-liquidity program.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that SHC’s sustainable cash flow will help generate solid debt service coverage.
More articles on healthcare finance:
MACRA update: More advanced APM opportunities to open
St. Joseph’s Hospital Health Center posts $13M loss
Goldman says these 25 healthcare stocks are immune from the election
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
